Metraipolis › archive › dc_f412b2498083

USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer — Europe PMC PMID:42230533

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42230533
DOI
10.1038/s41419-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-10-31T22:46:43.320Z
SHA-256 of the archived text
9e5630dc73de355b44669b723adbaac343e2da183414aa040207390182e4d015
Stable URL of this page
https://metraipolis.com/documento/dc_f412b2498083

How to cite

USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer — Europe PMC PMID:42230533 — Europe PMC (en), https://europepmc.org/article/MED/42230533 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f412b2498083 (Metraipolis archive dc_f412b2498083, sha256 9e5630dc73de355b44669b723adbaac343e2da183414aa040207390182e4d015)
BibTeX
@misc{dcf412b2498083,
  title = {USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer — Europe PMC PMID:42230533},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42230533},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f412b2498083; sha256 9e5630dc73de355b44669b723adbaac343e2da183414aa040207390182e4d015},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42230533. Agents can read the archived copy with the MCP tool read_document.